(1 - 6 von 7
)
Gilead to buy Kite for promising cancer therapies in $12 billion deal...
www.reuters.com
Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with...
Gilead to buy Kite Pharma for about $11 billion - MarketWatch
www.marketwatch.com
Gilead Sciences Inc. has agreed to pay about $11 billion for Kite Pharma Inc. and its promising new technology for harnessing the body's immune system to...
sortiert nach Relevanz / Datum